Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Observational

The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))

NCT05298982 · tracked via the Priya Life Science Australia tracker
Phase
Observational
Started
2020-02-11
Last updated
2022-03-28

Condition(s) studied

Critically IllMechanical VentilationLong Term Outcome

Investigational drug(s) / intervention(s)

Early activity and Mobilisation Intervention

Early activity and Mobilisation Intervention: The early activity and mobilisation intervention is comprised of exercises based on a reproducible, physiological approach using both strength and functional activities

Study summary

This study is a prospective cohort study to evaluate the long-term effects of early activity and mobilisation compared to standard care on disability, function and health status for patients at 1, 2 and 5 years after recruitment of patients randomised into the TEAM Phase III RCT (ClinicalTrials.gov NCT03133377). The primary outcome of the study will be the level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 12 level (WHODAS) at 2 years after recruitment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Enrolled in the TEAM Phase III RCT Protocol. Exclusion Criteria: * There are no exclusion criteria.

Primary outcome measure(s)

  • Level of disability measured with the World Health Organisation's Disability Assessment Schedule (WHODAS) 2.0 — Assessed 2 years after recruitment
    level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 2 level (WHODAS) at 2 years after recruitment.

Trial sites (16)

FacilityCityRegionStatus
Royal Prince Alfred Hospital Camperdown New South Wales
John Hunter Hospital Sydney New South Wales
Royal North Shore Hospital Sydney New South Wales
Wollongong Hospital Wollongong New South Wales
Sunshine Coast University Hospital Birtinya Queensland
Mater Health Brisbane Queensland
Mater Private Hospital Brisbane Queensland
Caboolture Hospital Caboolture Queensland
Redcliffe Hospital Redcliffe Queensland
Toowoomba Hospital Toowoomba Queensland
Launceston General Hospital Launceston Tasmania
Geelong Hospital - Barwon Health Geelong Victoria
Cabrini Hospital Malvern Victoria
Royal Melbourne Hospital Parkville Victoria
Alfred Hospital Prahran Victoria
Sunshine Hospital St Albans Victoria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05298982 on ClinicalTrials.gov ↗ ← All trials in Australia